Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist.

ASIA unversity > 醫學暨健康學院 > 生物科技學系 > 期刊論文 > Item 310904400/112091

請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/112091

題名:	Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist.
作者:	Ch, Chia-Chia;Chao, Chia-Chia;陳?均;Chi, Pei-Chen;Chiou, Pei-Chen;Hs, Chin-Jung;Hsu, Chin-Jung;Liu, Po-I;Liu, Po-I;Yang, Yi-Chen;Yang, Yi-Chen;Re, Russel J.;Reiter, Russel J.;Yang, Shun-Fa;Yang, Shun-Fa;湯智昕;Chih-Hsin;Tang
貢獻者:	生物科技學系
日期:	2019-03
上傳時間:	2019-09-18 03:46:20 (UTC+0)
摘要:	The epithelial-mesenchymal transition (EMT) phenotype, whereby mature epithelial cells undergo phenotype transition and differentiate into motile, invasive cells, has been indicated in tumor metastasis. The melatonin hormone secreted by the pineal gland has an antioxidant effect and protects cells against carcinogenic substances that reduce tumor progression. However, the effects of melatonin in EMT and lung cancer metastasis are largely unknown. We found that melatonin down-regulated EMT by inhibiting Twist/Twist1 (twist family bHLH transcription factor 1) expression. This effect was mediated by MT1 receptor, PLC, p38/ERK and β-catenin signaling cascades. Twist expression was positively correlated with tumor stage and negatively correlated with MT1 expression in lung cancer specimens. Furthermore, melatonin inhibited EMT marker expression and lung cancer metastasis to liver in vivo Finally, melatonin shows promise in the treatment of lung cancer metastasis and deserves further study.
關聯:	CLINICAL SCIENCE
顯示於類別:	[生物科技學系] 期刊論文

文件中的檔案:

沒有與此文件相關的檔案.

檢視Licence

在ASIAIR中所有的資料項目都受到原著作權保護.

資料載入中.....